A novel retro-inverso gonadotropin-releasing hormone (GnRH) immunogen elicits antibodies that neutralize the activity of native GnRH

Endocrinology

Volumn 144, Issue 7, 2003, Pages 3262-3269

  Fromme, B ^a   Eftekhari, P ^b,e   Van Regenmortel, M ^c   Hoebeke, J ^b   Katz, A ^a   Millar, R ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d MRC Reproductive Biology Unit   (United Kingdom)

^e FORENAP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FREUND ADJUVANT; GONADORELIN; GONADORELIN ANTIBODY; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; NEUTRALIZING ANTIBODY; RETRO INVERSO GONADOTROPIN RELEASING HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BIOSENSOR; CONTROLLED STUDY; DRUG EFFECT; ENZYME DEGRADATION; GONAD FUNCTION; GONADOTROPIN RELEASE; HORMONAL REGULATION; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RABBIT; VACCINATION;

ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CONTRACEPTIVE AGENTS; FEMALE; FREUND'S ADJUVANT; GONADOTROPIN-RELEASING HORMONE; IMMUNIZATION; INOSITOL PHOSPHATES; MALE; MICE; NEOPLASMS; RABBITS; VACCINES;

EID: 0037634540     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-221135     Document Type: Article

References (25)

1. Fink G 1988 Gonadotropin secretion and its control. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 1349-1377
2. Millar RP, King JA, Davidson JS, Milton RC 1987 Gonadotrophin-releasing hormone-diversity of functions and clinical applications. S Afr Med J 72:748-755
3. Casper RF 1991 Clinical uses of gonadotropin-releasing hormone analogues. Can Med Assoc J 144:153-158
4. Ghosh S, Jackson DC 1999 Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int Immunol 11:1103-1110
5. Beekman NJ, Schaaper WM, Turkstra JA and Meloen RH 1999 Highly immunogenic and fully synthetic peptide-carrier constructs targetting GnRH. Vaccine 17:2043-2050
6. Miller LA, Johns BE, Killian GJ 2000 Immunocontraception of white-tailed deer with GnRH vaccine. Am J Reprod Immunol 44:266-274
7. Talwar GP 1997 Vaccines for control of fertility and hormone-dependent cancers. Immunol Cell Biol 75:184-189
8. Talwar GP 1999 Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol Rev 171:173-192
9. Jacobs E, Watson SA, Michaeli D, Ellis IO, Robertson JF 1999 Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts. Br J Cancer 80:352-359
10. Van Regenmortel MH, Guichard G, Benkirane N, Briand JP, Muller S, Brown F 1998 The potential of retro-inverso peptides as synthetic vaccines. Dev Biol Stand 92:139-143
11. Muller S, Guichard G, Benkirane N, Brown F, Van Regenmortel MH, Briand JP 1995 Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. Pept Res 8:138-144
12. Benkirane N, Guichard G, Briand JP, Muller S 1996 Exploration of requirements for peptidomimetic immune recognition. Antigenic and immunogenic properties of reduced peptide bond pseudopeptide analogues of a histone hexapeptide. J Biol Chem 271:33218-33224
13. Benkirane N, Guichard G, Briand JP, Muller S, Brown F, Van Regenmortel MH 1996 Mimicry of viral epitopes with retro-inverso peptides of increased stability. Dev Biol Stand 87:283-291
14. Klinman DM, Barnhart KM, Conover J 1999 CpG motifs as immune adjuvants. Vaccine 17:19-25
15. Keown WA, Campbell CR, Kucherlapati RS 1990 Methods for introducing DNA into mammalian cells. Methods Enzymol 185:527-537
16. Millar RP, Davidson J, Flanagan CA, Wakefield I 1995 Ligand binding and second messenger assays for cloned Gq/G11-coupled neuropeptide receptors: the GnRH receptor. Methods Neurosci Receptor Mol Biol 25:145-162
17. Sealfon SC, Weinstein H, Millar RP 1997 Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev 18:180-205
18. Van Regenmortel MH 2000 Binding measurements as surrogate biological assays: surface plasmon resonance biosensors for characterizing vaccine components. Dev Biol 103:69-74
19. King JA, Millar RP 1995 Evolutionary aspects of gonadotropin-releasing hormone and its receptor. Cell Mol Neurobiol 15:5-23
20. Troskie B, King JA, Millar RP, Peng YY, Kim J, Figueras H, Illing N 1997 Chicken GnRH II-like peptides and a GnRH receptor selective for chicken GnRH II in amphibian sympathetic ganglia. Neuroendocrinology 65:396-402
21. White RB, Eisen JA, Kasten TL, Fernald RD 1998 Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci USA 95:305-309
22. Latimer VS, Rodrigues SM, Garyfallou VT, Kohama SG, White RB, Fernald RD, Urbanski HF 2000 Two molecular forms of gonadotropin-releasing hormone (GnRH-I and GnRH-II) are expressed by two separate populations of cells in the rhesus macaque hypothalamus. Brain Res Mol Brain Res 75:287-292
23. Jones SW 1987 Chicken II luteinizing hormone-releasing hormone inhibits the M-current of bullfrog sympathetic neurons. Neurosci Lett 80:180-184
24. Ladd A, Tsong YY, Walfield AM, Thau R 1994 Development of an antifertility vaccine for pets based on active immunization against luteinizing hormone-releasing hormone. Biol Reprod 51:1076-1083
25. Talwar GP 1997 Fertility regulating and rrnmunotherapeutic vaccines reaching human trials stage. Hum Reprod Update 3:301-310